Experience With Therapeutic Plasma Exchange in the Pediatric Nephrology Unit of Sohag University Hospital

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

25 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-08-15

Study Completion Date

2026-08-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Plasmapheresis also known as a therapeutic plasma exchange (TPE) TPE is an extracorporeal blood purification technique designed for the removal of large-molecular-weight substances. Examples of these substances include pathogenic autoantibodies, immune complexes, cryoglobulins, myeloma light chains, endotoxin, and cholesterol-containing lipoproteins Document the indications, procedures, outcomes, and complications associated with TPE in pediatric patients at Sohag University Hospital.

To compare our findings with existing national and international data to identify areas for improvement and standardization.

To evaluate the safety and efficacy of TPE in our pediatric nephrology unit.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Therapeutic Plasma Exchange Followed by Convalescent Plasma Transfusion in Severe and Critically Ill COVID-19 Patients

NCT04973488

COVID-19 Pneumonia COVID-19 Respiratory Infection Acute Respiratory Failure +1 more

COMPLETED NA

Safety and Efficacy of PolyHeme(R) in Hemorrhagic Shock Following Traumatic Injuries Beginning in the Pre-Hospital Setting

NCT00076648

Hemorrhagic Shock

UNKNOWN PHASE3

Efficacy of Tranexamic Acid on Blood Loss During Percutaneous Nephrolithotomy.

NCT04367155

Renal Stones Nephrolithiasis

UNKNOWN NA

STUDY OF SURVIVAL AND FUNCTIONALITY IN CRYOPRESERVED PLATELETS

NCT04754841

Platelet Cryopreservation Platelet Survival

UNKNOWN NA

Impact of Tranexamic Acid Use in Percutaneous Nephrolithotomy

NCT02966236

Nephrolithiasis Staghorn Calculus

UNKNOWN PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Experience With Therapeutic Plasma Exchange in the Pediatric Nephrology Unit

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

All pediatric patients (aged 1-18 years) who underwent TPE during the study period.

Both male and female.

Exclusion Criteria

Patients who cannot tolerate central line placement Patients who are in an actively septic state or are hemodynamically unstable . Patients who have allergies to fresh frozen plasma (FFP) or albumin, depending on the type of plasma exchange

Minimum Eligible Age

1 Year

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No